Education
About Us
Working with TipRanks
Follow Us
Sagimet Biosciences, Inc. Class A (SGMT)
NASDAQ:SGMT
Total Valuation
Sagimet Biosciences, Inc. Class A has a market cap or net worth of $219.49M. The enterprise value is $106.13M.
Market Cap$219.49M
Enterprise Value$106.13M
Share Statistics
Sagimet Biosciences, Inc. Class A has 31,001,108 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding31,001,108
Owned by Insiders10.18%
Owned by Institutions9.10%
Financial Efficiency
Sagimet Biosciences, Inc. Class A’s return on equity (ROE) is -0.29 and return on invested capital (ROIC) is -34.92%.
Return on Equity (ROE)-0.29
Return on Assets (ROA)-0.28
Return on Invested Capital (ROIC)-34.92%
Return on Capital Employed (ROCE)-0.35
Revenue Per Employee0.00
Profits Per Employee-3.25M
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Sagimet Biosciences, Inc. Class A is ―. Sagimet Biosciences, Inc. Class A’s PEG ratio is 0.59.
PE Ratio―
PS Ratio0.00
PB Ratio0.91
Price to Fair Value0.91
Price to FCF-3.32
Price to Operating Cash Flow-5.65
PEG Ratio0.59
Income Statement
In the last 12 months, Sagimet Biosciences, Inc. Class A had revenue of 0.00 and earned -45.57M in profits. Earnings per share was -1.45.
Revenue0.00
Gross Profit0.00
Operating Income-54.45M
Pretax Income-45.57M
Net Income-45.57M
EBITDA-45.57M
Earnings Per Share (EPS)-1.45
Cash Flow
In the last 12 months, operating cash flow was -44.84M and capital expenditures 0.00, giving a free cash flow of -44.84M billion.
Operating Cash Flow-44.84M
Free Cash Flow-44.84M
Free Cash Flow per Share-1.45
Dividends & Yields
Sagimet Biosciences, Inc. Class A pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.34
52-Week Price Change24.43%
50-Day Moving Average7.58
200-Day Moving Average6.12
Relative Strength Index (RSI)43.35
Average Volume (3m)560.48K
Important Dates
Sagimet Biosciences, Inc. Class A upcoming earnings date is Mar 30, 2026, After Close (Confirmed).
Last Earnings DateNov 13, 2025
Next Earnings DateMar 30, 2026
Ex-Dividend Date―
Financial Position
Sagimet Biosciences, Inc. Class A as a current ratio of 34.30, with Debt / Equity ratio of 0.10%
Current Ratio34.30
Quick Ratio34.30
Debt to Market Cap<0.01
Net Debt to EBITDA1.66
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Sagimet Biosciences, Inc. Class A has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Sagimet Biosciences, Inc. Class A EV to EBITDA ratio is -1.43, with an EV/FCF ratio of -1.54.
EV to Sales0.00
EV to EBITDA-1.43
EV to Free Cash Flow-1.54
EV to Operating Cash Flow-1.54
Balance Sheet
Sagimet Biosciences, Inc. Class A has $116.69M in cash and marketable securities with $115.00K in debt, giving a net cash position of $116.58M billion.
Cash & Marketable Securities$116.69M
Total Debt$115.00K
Net Cash$116.58M
Net Cash Per Share$3.76
Tangible Book Value Per Share$4.97
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Sagimet Biosciences, Inc. Class A is $28.57, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$28.57
Price Target Upside303.53% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast―
EPS Growth Forecast-38.23%